mycosis fungoides-type CTCL
Dermatology · 2023–2023
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| chlormethine hydrochloride Topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) in adult patients with no more than 25% body surface area involved, who have… | Nov 2023 | Recommended with restriction | input received Rare Cancers Australia |
Who spoke
Rare Cancers Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.